Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain penetrating peptides and peptide–drug conjugates to overcome the blood–brain barrier and target CNS diseases
Xue Zhou, Quentin R. Smith, Xinli Liu
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2021) Vol. 13, Iss. 4
Closed Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

Peptide–drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?
Chen Fu, Lifeng Yu, Yuxi Miao, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 498-516
Open Access | Times Cited: 111
A nitric-oxide driven chemotactic nanomotor for enhanced immunotherapy of glioblastoma
Huan Chen, Ting Li, Xiaogang Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 97
Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases
Yishu Fan, Zhuohui Chen, Mengqi Zhang
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 90
Ultrasound-mediated blood–brain barrier opening: An effective drug delivery system for theranostics of brain diseases
Jieqiong Wang, Zhenzhou Li, Min Pan, et al.
Advanced Drug Delivery Reviews (2022) Vol. 190, pp. 114539-114539
Closed Access | Times Cited: 79
Cell–cell communication: new insights and clinical implications
Jimeng Su, Ying Song, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 31
Peptide-Drug Conjugates: Design, Chemistry, and Drug Delivery System as a Novel Cancer Theranostic
Syed Faheem Askari Rizvi, Lin‐Jie Zhang, Haixia Zhang, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 2, pp. 309-334
Open Access | Times Cited: 16
Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment
Young‐Ju Jang, Seong-Jun Kang, Hyun Su Park, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Drug conjugate-based anticancer therapy - Current status and perspectives
Yuqi Yang, Shuhang Wang, Peiwen Ma, et al.
Cancer Letters (2022) Vol. 552, pp. 215969-215969
Open Access | Times Cited: 61
It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy
Che-Pei Kung, Jason D. Weber
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 48
Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges
Sofia Parrasia, Ildikò Szabó, Mario Zoratti, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 11, pp. 3700-3729
Open Access | Times Cited: 38
Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood–Brain Barrier (BBB)
Soma Mondal Ghorai, Auroni Deep, Devanshi Magoo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1999-1999
Open Access | Times Cited: 34
Cell-Penetrating Peptides: Promising Therapeutics and Drug-Delivery Systems for Neurodegenerative Diseases
Mitra Pirhaghi, Fatemeh Mamashli, Faezeh Moosavi-Movahedi, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 5, pp. 2097-2117
Closed Access | Times Cited: 15
Engineering peptide drug therapeutics through chemical conjugation and implication in clinics
Syed Faheem Askari Rizvi, Haixia Zhang, Quan Fang
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2420-2471
Closed Access | Times Cited: 10
Advancements in current one-size-fits-all therapies compared to future treatment innovations for better improved chemotherapeutic outcomes: a step-toward personalized medicine
Nadia Μ. Hamdy, Emad B. Basalious, Mona G. El-Sisi, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 11, pp. 1943-1961
Closed Access | Times Cited: 10
Mechanistic insight into glioma through spatially multidimensional proteomics
Lei Shen, Zhourui Zhang, Pengfei Wu, et al.
Science Advances (2024) Vol. 10, Iss. 7
Open Access | Times Cited: 8
Antimicrobial cyclic peptides effectively inhibit multiple forms of Borrelia and cross the blood-brain barrier model
Evelína Mochnáčová, Katarína Bhide, Katarína Kucková, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Polymeric Nanoparticles Properties and Brain Delivery
Laís Ribovski, Naomi M. Hamelmann, Jos M. J. Paulusse
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2045-2045
Open Access | Times Cited: 47
Biological Membrane-Penetrating Peptides: Computational Prediction and Applications
Ewerton Cristhian Lima de Oliveira, Kauê Santana da Costa, Paulo Sérgio Taube, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 31
New Drug Delivery Systems Developed for Brain Targeting
Shruti Rawal, Bhoomika M. Patel, Mayur M. Patel
Drugs (2022) Vol. 82, Iss. 7, pp. 749-792
Closed Access | Times Cited: 31
Polylactic-Co-Glycolic Acid-Based Nanoparticles Modified with Peptides and Other Linkers Cross The Blood–Brain Barrier for Targeted Drug Delivery
Yue Na, Ning Zhang, Xinyu Zhong, et al.
Nanomedicine (2023) Vol. 18, Iss. 2, pp. 125-143
Closed Access | Times Cited: 18
Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles—Focus on Alzheimer's and Parkinson's disease
Sara Hernando, Edorta Santos‐Vizcaíno, Manoli Igartúa, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 15, Iss. 5
Open Access | Times Cited: 16
A recognition of exosomes as regulators of epigenetic mechanisms in central nervous system diseases
Shunxin Hu, Lei Feng, Zhonghong Yang, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 7
Small Molecule–Drug Conjugates Emerge as a New Promising Approach for Cancer Treatment
Tiansi Wang, Meichai Li, Ruting Wei, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 3, pp. 1038-1055
Closed Access | Times Cited: 6
Platelet-Tumor Cell Hybrid Membrane-Camouflaged Nanoparticles for Enhancing Therapy Efficacy in Glioma
Lingling Wu, Qin Li, Junjie Deng, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 8433-8446
Open Access | Times Cited: 38
BBPpredict: A Web Service for Identifying Blood-Brain Barrier Penetrating Peptides
Xue Chen, Qianyue Zhang, Bowen Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top